Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity.
Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity. Arch Ophthalmol. 2012 Jun; 130(6):801-2.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized
Bevacizumab
Disease Progression
Gestational Age
Humans
Infant, Extremely Low Birth Weight
Infant, Newborn
Intravitreal Injections
Recurrence
Retinal Detachment
Retinopathy of Prematurity
Treatment Failure
Ultrasonography
Vascular Endothelial Growth Factor A
authors with profiles
Michael P Blair